Common Contracts
3 similar Securities Purchase Agreement contracts by Akari Therapeutics PLC, Mereo Biopharma Group PLC
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 1st, 2020 • Akari Therapeutics PLC • Pharmaceutical preparations • Illinois
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 30, 2020, by and between AKARI THERAPEUTICS, PLC, a public limited company (with registered number 5252842) incorporated under the laws of England and Wales (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 10th, 2020 • Mereo Biopharma Group PLC • Pharmaceutical preparations • Illinois
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 10, 2020, by and between MEREO BIOPHARMA GROUP PLC, a public limited company incorporated under the laws of England and Wales (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 27th, 2018 • Akari Therapeutics PLC • Pharmaceutical preparations • Illinois
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 26, 2018, by and between AKARI THERAPEUTICS, PLC, a public limited company incorporated under the laws of England and Wales (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
